Similar documents
Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006

Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register

Risks and complications of assisted conception

Assisted Reproductive Technologies at IGO

European IVF Monitoring (EIM) Year: 2008

Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao.

Pregnancy Outcomes After Assisted Reproductive Technology

Recent Progress in In Vitro Fertilization and Intracytoplasmic Sperm Injection Technologies in Japan

Clinical Policy Committee

Fertility Facts and Figures 2008

In - Vitro Fertilization Handbook

Reproductive Technology. Chapter 21

Assisted reproductive technology in Australia and New Zealand 2010

AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG.

Areas of Concern. Reproductive Ethics: Issues &

OHTAC Recommendation. In Vitro Fertilization and Multiple Pregnancies

Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY

European IVF Monitoring (EIM) Year: 2010

Preimplantation Genetic Diagnosis (PGD) in Western Australia

In Vitro Fertilization (IVF) Page 1 of 11

FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?

Ethical issues in assisted reproductive technologies. Effy Vayena

Balanced. translocations. rarechromo.org. Support and Information

East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014

Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services.

Preimplantation Genetic Diagnosis. Evaluation for single gene disorders

Lesbian Pregnancy: Donor Insemination

Preimplantation genetic screening (PGS)

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

The Genetics of Beckwith Wiedemann Syndrome (BWS)

Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2

LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD

INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES

Singleton Siblings - Spontaneous Conception and Weight Gain

Consent for Frozen Donor Oocyte In Vitro Fertilization and Embryo Transfer (Recipient)

The following chapter is called "Preimplantation Genetic Diagnosis (PGD)".

Topic: Male Factor Infertility

Assisted reproductive technologies in Canada: 2005 results from the Canadian Assisted Reproductive Technologies Register

Clinical Reference Group Quality & Safety Committee Governing Body. Policy Screened

Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota

Ehlers-Danlos Syndrome Fertility Issues. Objectives

Authorized By: Holly C. Bakke, Commissioner, Department of Banking and Insurance.

IN VITRO FERTILIZATION AND CEREBRAL PALSY: THE PETŐ INSTITUTE EXPERIENCE

CONSENT TO PARTICIPATE IN THE IN VITRO FERTILIZATION-EMBRYO TRANSFER PROGRAM

REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN (651)

Age and Fertility. A Guide for Patients PATIENT INFORMATION SERIES

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER

Preimplantation Genetic Diagnosis (PGD) for Fanconi Anemia and HLA matching

Assisted reproductive technologies (ARTs): Evaluation of evidence to support public policy development

How to choose an IVF clinic and understand success rates: Questions to ask when choosing an IVF clinic.

טופס הסכמה לטיפולי הפרייה חוץ גופית

it right? activity (page 4) to highlight ethical issues associated with IVF

Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups

Tower Hamlets CCG Fertility policy

Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy

IVF OVERVIEW. Tracy Telles, M.D.

Fast Track to IVF. Objectives

University Hospitals Coventry and Warwickshire NHS Trust. Centre for Reproductive Medicine. We Care. We Achieve. We Innovate.

Male Infertility and Intracytoplasmic Sperm Injection (ICSI) in the Middle East

Fertility care for women diagnosed with cancer

A POWERFUL IN VITRO FERTILIZATION

In vitro fertilization is associated with an increase in major birth defects

Human Cloning The Science and Ethics of Nuclear Transplantation

Chapter 16 Reproductive Technology, Gene Therapy, and Stem Cells (modified)

Assisted Conception Policy. February Dr. Liz Saunders Cyril Haessig

Consent for In Vitro Fertilization

FREEDOM OF INFORMATION ACT 2000 Birmingham CrossCity CCG Ref: FOI/ IVF Funding Policy

IN VITRO FERTILISATION IVF and ICSI

The Developing Person Through the Life Span 8e by Kathleen Stassen Berger

How To Get A Refund On An Ivf Cycle

Midland Fertility Services

Pregnancy Outcomes After Assisted Human Reproduction

Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)

Medical Policy Preimplantation Genetic Testing

FREQUENTLY ASKED QUESTIONS ABOUT IVF

Nordic Fertility Society. Quality Guide. Checklist for ART Clinic and ART laboratory

Egg Donation Process, Risk, Consent and Agreement

Heritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait

REI Pearls: Pitfalls of Genetic Testing in Miscarriage

THE birth of Louise Brown in 1978

IVF. IVF: The Success of Technology. Recent Advances in Assisted Reproductive Technologies 10/20/2007

IVF MONEY-BACK PLAN IN PARTNERSHIP WITH

In Vitro Fertilization

Perinatal Complications of Assisted Reproduction

Human Embryology. Weeks 1-4

Disclosure. Objectives 2/21/2016

Project proposal. Reproductive tourism in India: A description of surrogate mothers and their offspring. Medical student Malene Tanderup Kristensen

The relevant NICE Clinical Guidance 156, Fertility can be accessed here:

SO, WHAT IS A POOR RESPONDER?

Transitioning from IVF practice to restorative reproductive medicine.

In Vitro Fertilization and Multiple Pregnancies

, hereby agree to a form of treatment known

Genetics and Pregnancy Loss

Illinois Insurance Facts Illinois Department of Insurance

Fertility-related choices. A decision aid for younger women with early breast cancer

Act of 5 December 2003 No. 100 relating to the application of biotechnology in human medicine, etc

Consent for Treatment

DARTMOUTH-HITCHCOCK MEDICAL CENTER Lebanon, New Hampshire IN VITRO FERTILIZATION PROCEDURE DESCRIPTION

What women can do to optimise their health during pregnancy and that of their baby Claire Roberts

CT FERTILITY ASSOCIATES Informed Consent for Frozen Embryo Transfer

Transcription:

DOES ASSISTED REPRODUCTIVE TECHNOLOGY (ART) INCREASE THE RISK OF BIRTH DEFECTS? JOE LEIGH SIMPSON, M.D. SENIOR VICE PRESIDENT FOR RESEARCH AND GLOBAL PROGRAMS MARCH OF DIMES FOUNDATION WHITE PLAINS, NY, USA Teratology Society, 2012 Disclosures Current Advisory Boards and Consultation BioDx Novartis Bayer

MULTIPLE GESTATIONS AND ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) In U.S. 30% pregnancy rate with 3% triplets and 30% twins. In U.K. 20% pregnancy rate, < 10% twins and 1% triplets Multiple l gestations ti lead to complications due to neonatal sequelae of prematurity. Half of all ART babies in the U.S. are a twin or triplet MULTIPLE GESTATIONS AND ART: Birth Weight Lower birth weight in twin gestations, but similar whether natural or assisted reproduction. That little to no change occurs in birth weight in ART twins suggests underlying maternal predisposition (related to difficulty conceiving). In singletons, however, odds ratio = 3 for very low birth weight or = 2.2 for premature birth and for perinatal morality.

MULTIPLE GESTATIONS AND ART: Birth Defects Birth defects increased in both monozygotic (MZ) and dizygotic twins in general population and would be expected in ART twins for this reason alone. Certain ART methods (blastocyst transfer) increase MZ twinning, independent of ovulation stimulation. BIRTH DEFECTS AND ART Are structural malformations increased? Are chromosomal abnormalities increased?

REGISTRIES ASSESSING ANOMALIES IN ART / IVF IVF alone: (prior to 1993) Intra ntracytoplasmic Sperm Injection (ICSI): 1993 onward. Approximately half ART cycles. AUSTRALIA NEW ZEALAND ART (1979-1993) 1993) Singleton Births Malformations IVF 6388 185 (2.9%) GIFT 3409 99 (2.9%) IVF alone without ICSI: Risk not considered increased for many years Lancaster, 1995

ICSI AND DE NOVO CHROMOSOMAL ABERRATIONS ICSI General Offspring Population Sex chromosomal 9 (0.83%) ~ 0.2% Numerical Autosomal 9 (0.83%) ~ 0.2-0.6% 0.6% Numerical 5 Structural 4 TOTAL 18 (1.66%) 0.45% Data: Bonduelle et al., 1998

HYPOSPADIAS IN ICSI OFFSPRING - Wennerholm et al. (2000): RR 3.0 (1.09-6.50) compared to Swedish Medical Birth Registry and Registry of Congenital Malformation - Ericson and Kallen (2001): RR 1.5 (1.0-2.1) - Klemetti et al (2005)- 76/10,000 v 29/10,000 ICSI FATHERS AND HYPOSPADIAS IN OFFSPRING Hypospadias p is polygenic / multifactorial with 2.5% recurrence risk for first-degree relatives Gonadal abnormalities that necessitate ICSI for fertilization could result in decreased hormone production in father and fetus and thus hypospadias

POPULATION-BASED STUDIES (IVF and ICSI) Western Australia (Perth): 30-40% increase in birth defects (Hansen et al., 2005) Finland (Registry-based): Odds ratio 1.3 (95% confidence limits 11 1.1 1.6) 16) comparing 4559IVF 4,559 IVF, 4,467 other ART and 27,078 controls. Hansen, 2005

META-ANALYSISANALYSIS 19 studies IVF or ICSI Odds ratio for birth defects 1.29 (95% confidence limits 1.01-1.67). 1.67). Insufficient power to evaluate individual anomalies. Hypospadias greatest risk; others arguable (cardiovascular, musculoskeletal, l l gastrointestinal, neural tube defects). Maternal age higher in IVF/ICSI Rimm et al. ASSISTED CONCEPTIONS AND BIRTH DEFECTS STUDY DESIGN (DAVIES, 2012) South Australia Registry Birth defects sought before 5 th Birthday Included terminations for anomalies <20 weeks, within 28 days birth, or reported from multiple other sources 6163 Assisted conceptions/ 308,974 births 1986-2002 Multiple (p<0.001) differences between assisted and spontaneous conceptions age, socioeconomic status, race, nulliparity, paternal occupation, smoking, multiple gestation, diabetes, anemia. Davies et al., 2012

BIRTH DEFECTS ADJUSTED AND UNADJUSTED Conceptions Percentage* Unadjusted Odds Ratio Adjusted All Assisted 8.3% 1.47 1.28 All Spontaneous 5.8% IVF alone 7.2% 1.26 1.07 (0.90-1.26) ICSI alone 9.9% 1.77 1.57 (1.30-1.90) 1.90) Includes terminations <20 weeks, livebirths 1-28 days and any reported anomaly <5 years Davies et al., 2012 NEJM ADJUSTED BIRTH DEFECTS BY PROCEDURE (SINGLETONS) PROCEDURE Fresh IVF 105 1.05 (0.82-1.35) 135) Frozen IVF 1.08 (0.76-1.53) Fresh ICSI 1.73 (1.35-2.21) Frozen ICSI 1.70 (0.65-1.85) Donor Insemination 1.37 (0.98-1.92) Intrauterine Insemination 1.46 (1.09-1.95) 1.95) Clomiphene at home 3.19 (1.32-7.69) Spontaneous after prior ART 1.26 (1.01-1.57) 1.57) Subfertile without ART 1.37 (1.02-1.83) Davies et al., 2012

Are increased risks related to ART per se? Or, Do increased risks relate to underlying reason why ART needed? TECHNICAL VARIABLES IN ART Ovulation stimulation regimes Obtaining and handling gametes Embryo culture Cryopreservation

HANDLING SPERM Polyvinylpyrolidone (PPV) to slow sperm Hyperosmotic swelling (of sperm tail) with sodium citrate, fructose Media (Hepes Hepes) Light source Air OOCYTE ASPIRATION AND HANDLING Type media: Earle s; heparin Air: 80% N, 10% O, 10 % room air, or 90% N, 5% O, 5% 4oom air Hepafiltration?

EMBRYO CULTURE Media composition not also disclosed (Proprietary) Supplementation: - ± human or maternal serum albumin - ± synthetic serum substitute - ± bovine serum albumin (no longer used) Traditional culture medias developed for first three days, but now cultures must extend to five days BLASTOMERE (DAY 3-4)

BLASTOCYST (DAY 5-6) LENGTH OF TIME IN CULTURE One third of cleavage stage embryos do not survive in vitro to day 5 - Selection against aneuploidy? - What is the appropriate culture media for days 3-5/6?

CONCLUSION: TECHNICAL VARIABLES Multiple at each step Plausible that certain variables differentially deletinously compared to in vivo conception, either through ovulation stimulation or embryo culture CRYOPRESERVATION Cleavage stage embryos having fewer cells upon thawing show lower pregnancy rates Do epigenetic changes arise during cyropreservation?

Or, Are increased risks related to ART per se? Do increased risks relate to underlying reason why ART needed? Different populations POPULATION REQUIRING INFERTILITY TREATMENT 10% of population (equal male and female) Differs from general population Older age May have genetic disorders with implications for offspring (e.g., Kartagener syndrome, cystic fibrosis), in both male and female partners Increased balanced translocations in both male and female partners.

AGE DISTRIBUTION OF WOMEN WHO HAD ART CYCLES USING FRESH NONDONOR EGGS OR EMBRYOS, 2001 INCREASED TRANSLOCATIONS IN COUPLES UNDERGOING ICSI (PER 1,000) Female Male Newborns Rcp 6.9 12.3 1.52 Rob 6.9 8.2 0.90 Inv 6.9 69 1.4 14 0.42 042 Total 20.7 21.9 2.84 (2.07%) (2.19%) (0.28%) Gekas et al., Hum. Reprod., 2001

Do increased risks relate to why ART needed? Difficulty in conceiving confers increased risk irrespective of therapy No true comparison group (infertile women not undergoing ART) SUBFERTILITY AND BIRTH DEFECTS Danish national birth cohort; interviews determined infertility history 50,897 singleton and 1366 twins of fertile couples; Time to pregnancy (TTP) < 12 months) 5764 singleton and 100 twins; TTP > 12 months, but natural conception v 4588 singleton and 1690 twins undergoing infertility treatment (singleton 398 ICSI; 1483 IVF; others hormonal, surgery, IUI) OR 1.2 Birth Defects Zhu et al., BMJ 2006

ADJUSTED BIRTH DEFECTS BY PROCEDURE (SINGLETONS) PROCEDURE Fresh IVF 105 1.05 (0.82-1.35) 135) Frozen IVF 1.08 (0.76-1.53) Fresh ICSI 1.73 (1.35-2.21) Frozen ICSI 1.70 (0.65-1.85) Donor Insemination 1.37 (0.98-1.92) Intraveterine Insemination 1.46 (1.09-1.95) 1.95) Clomiphene at home 3.19 (1.32-7.69) Spontaneous after prior ART 1.26 (1.01-1.57) 1.57) Subfertile without treatment 1.37 (1.02-1.83) 1.83) Davies et al 2012 SUBFERTILITY AND BIRTH DEFECTS (SINGLETON PREGNANCIES) Adjusted Hazard Ratio Subfertile but natural Infertile and treated Total 1.20 (1.07 to 1.35) 1.39 (1.23 to 1.57) Circulatory 1.25 (0.97 to 2.15) 1.21 (0.91 to 1.62) Genital 0.81 (0.48 to 1.38) 2.03 (1.37 to 3.01) Ui Urinary system 107(068t 1.07 (0.68 to 169) 1.69) 145(094t 1.45 (0.94 to 224) 2.24) Chromosomal 0.68 (0.33 to 1.41) 0.98 (0.50 to 1.89) Digestive 1.51 (1.04 to 2.14) 1.44 (9.94 to 2.22) Nervous 2.01 (1.21 to 3.34) 1.39 (1.23 to 1.57) Davies et al 2012

CLOMIPHENE AND BIRTH DEFECTS Adjusted Odds Ratio/95% conf. interval Anencephaly 2.3 (1.1-4.7) Dandy-Walker 44(17-11 4.4 (1.7-11.6) 11.6) Cardiac-Septal 1.6 (1.1-2.2) - Muscular 4.9 (1.4-16.8) 16.8) Coarction Aorta 1.8 (1.1-3.0) Esophageal atresia 2.3 (1.3-4.0) Exstrophy cloaca 5.4 (1.6-19.3) 19.3) Omphalocele 2.2 (1.1-4.5) Craniosynostosis 1.9 (1.2-3.0) Reefhuis, Human Reprod 26:451-457,2001 457,2001. What mechanism might be disturbed in both infertility and birth defects? Chromosomal Imprinting

Chromosomal IMPRINTING AS EXPLANATION FOR INCREASED BIRTH DEFECTS?

CHROMATIN MODIFICATIONS Histone methylation Histone deacetylation Other ART AND BECKWITH - WIEDEMANN SYNDROME (BWS) Overgrowth syndrome (BWS) reminiscent of certain animal models. De Braun (2003): 7 of 65 cases associated with ART Of the 7, 5 required ICSI Cases studied (N = 6) had imprinting perturbations (LIT1 or H19) involving maternal allele, an uncommon molecular basis for BWS

BWS RESEARCH CENTRE (Birmingham, U.K.).) 149 BWS cases: 3 IVF alone 3 ICSI with IVF Unscheduled maternally expression 11p alleles Maher et al, J Med Genet, 2003 BECKWITH-WIEDEMANN WIEDEMANN SYNDROME 6 kb band: methylated 4.2 kb band: unmethylated

DIFFERENTIAL GENE EXPRESSIONS WITH DIFFERENT EMBRYO CULTURE MEDIA Mouse embryos in Whitten s media misexpressed 114 genes (Affymetrix microarray chip) compared to in vivo embryos Incubation in KSOM / AA medium misexpressed 29 genes Rinaudo and Schultz, Reproduction 128:301, 2004 EPIGENETIC PERTURBATION IN SPERM OF INFERTILE MALES MTHR, PAX 8, NTF3, SFN, HRAS Hypermethylation IGF2, H19 Decreased methylation RASGRF1 GTL2, PLAG1, MEST, KCND1 LIT1, SNRPN H3K4me, H3K27 me Locus specific hypermethylation Histone retention (nucleosomes)

IMPRINTING DISORDERS AND HUMAN ART REGISTRIES No technical feature common to birth defects associated with ART. Population-based (vital statistics) studies in Scandinavia show no increased risk overall or for any specific anomaly. Even if results were to show large relative risk the absolute effect is small because imprinting disorders are rare. CONCLUSIONS : BIRTH DEFECTS AND ART 1. Overall malformation rate slightly increased (relative risk 1.3 1.4). Only specific abnormalities hypospadias and sex chromosomal abnormalities (0.6% ) in Intracytoplasmic sperm injection (ISCI) 2. Myriad of technical variables in ART, so deleterious effect plausible. 3. ART couples not representative of the general population; thus, true control group not possible for robust comparison.

CONCLUSIONS 4. Birth defects increased in subfertile couples not requiring ART. 5. Imprinting perturbations plausible and consistent with animal studies and sperm studies, but data inconclusive and would likely confer low absolute risk even if present. 6. Trend toward single embryo transfer with 5-6 day blastocyst could further perturb imprinting and does increase frequency of monozygotic twins.